Journal
EUROPEAN RADIOLOGY
Volume 17, Issue 4, Pages 861-872Publisher
SPRINGER
DOI: 10.1007/s00330-006-0431-y
Keywords
BOLD-MRI; cancer; Cu-ATSM-PET; F-MISO-PET; hypoxia; radiotherapy; tumour resistance
Funding
- NCI NIH HHS [P01 CA042045, CA42045] Funding Source: Medline
Ask authors/readers for more resources
Tumour hypoxia represents a significant challenge to the curability of human tumours leading to treatment resistance and enhanced tumour progression. Tumour hypoxia can be detected by non-invasive and invasive techniques but the inter-relationships between these remains largely undefined. F-18-MISO and Cu-ATSM-PET, and BOLD-MRI are the lead contenders for human application based on their non-invasive nature, ease of use and robustness, measurement of hypoxia status, validity, ability to demonstrate heterogeneity and general availability, these techniques are the primary focus of this review. We discuss where developments are required for hypoxia imaging to become clinically useful and explore potential new uses for hypoxia imaging techniques including biological conformal radiotherapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available